Patrick Lydon
Impact in
- Health top 2%
- Vaccine Coverage and Hesitancy
Papers in
- Co-authors
- Michel Zaffran (4 shared papers)Gian Gandhi (3 shared papers)Laure B. Dumolard (3 shared papers)John Lloyd (2 shared papers)Rudolf Eggers (4 shared papers)Marta Gacic-Dobo (2 shared papers)Logan Brenzel (3 shared papers)Jean‐Marie Okwo‐Bele (5 shared papers)
- Journals
- Vaccine (10 papers)The Lancet (3 papers)Health Policy and Planning (1 paper)Bulletin of the World Health Organization (1 paper)Vaccine X (1 paper)
- Partner nations
- SwitzerlandUnited StatesIreland
In The Last Decade
Patrick Lydon
23 papers receiving 924 citations
Patrick Lydon's Hit Papers
Peers
Comparison fields: 5 of 103
- Health 328
- Medical Laboratory Technology 15
- Infectious Diseases 250
- Management Information Systems 83
- Microbiology 36
Countries citing papers authored by Patrick Lydon
This map shows the geographic impact of Patrick Lydon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Lydon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Lydon more than expected).
Fields of papers citing papers by Patrick Lydon
This network shows the impact of papers produced by Patrick Lydon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Lydon. The network helps show where Patrick Lydon may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Lydon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses Hit paper breakdown → | 2022 | 290 |
| 2 | 2015 | 96 | |
| 3 | 2014 | 72 | |
| 4 | 2014 | 68 | |
| 5 | 2017 | 61 | |
| 6 | 2006 | 51 | |
| 7 | 2008 | 47 | |
| 8 | 2013 | 45 | |
| 9 | 2015 | 37 | |
| 10 | 2014 | 36 | |
| 11 | 2008 | 34 | |
| 12 | 2014 | 30 | |
| 13 | 2008 | 27 | |
| 14 | Financial challenges of immunization: a look at GAVI. | 2004 | 25 |
| 15 | 2012 | 22 | |
| 16 | 2014 | 20 | |
| 17 | 2017 | 16 | |
| 18 | 2005 | 13 | |
| 19 | 2020 | 12 | |
| 20 | 2017 | 8 |
About Patrick Lydon
Patrick Lydon is a scholar working on Health, Finance, Economics and Econometrics, Management Information Systems and Microbiology, having authored 24 papers that have together received 1k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (15 papers), Pharmaceutical Economics and Policy (11 papers), Healthcare Systems and Reforms (7 papers), Supply Chain and Inventory Management (3 papers), Pharmaceutical Quality and Counterfeiting (2 papers), Bacterial Infections and Vaccines (2 papers), Forest Biomass Utilization and Management (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Health (328 citations), Medical Laboratory Technology (15 citations), Infectious Diseases (250 citations), Management Information Systems (83 citations) and Microbiology (36 citations). Patrick Lydon has collaborated with scholars based in Switzerland, United States and Ireland. Frequent co-authors include Michel Zaffran, Gian Gandhi, Laure B. Dumolard, John Lloyd, Rudolf Eggers, Marta Gacic-Dobo, Logan Brenzel, Jean‐Marie Okwo‐Bele, Jos Vandelaer and Saleena Subaiya. Their work appears in journals such as Vaccine, The Lancet, Health Policy and Planning, Bulletin of the World Health Organization and Vaccine X.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.